Q2 2021 Taro Pharmaceutical Industries Ltd Earnings Call Transcript
Good morning, ladies and gentlemen, and welcome to the Taro Pharmaceutical's second quarter earnings conference call. (Operator Instructions). As a reminder, this conference call is being recorded. I would now like to turn the call over to your host today, Mr. William Coote, Assistant Vice President and Treasurer. Please go ahead, sir.
Thank you. Good morning, everyone, and welcome to our second quarter 2020-'21 earnings conference call. We hope everyone is healthy and safe during these trying times, and since safety is our top priority, we are conducting a virtual call. Joining me today are Mr. Dilip Shanghvi, Chairman of the Board of Directors; Mr. Uday Baldota, Taro's CEO; and Ms. Daphne Huang, Taro's CFO.
We hope you have received a copy of the earnings press release, which can be found on our website at taro.com. We anticipate that many of you may have questions concerning not only this quarter's and year-to-date financial performance,
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |